Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
FXG vs PBJ: Two Different Paths to Consumer Staples Exposure

FXG vs PBJ: Two Different Paths to Consumer Staples Exposure

Key Takeaways

  • Both FXG and PBJ are smart-beta, rules-based ETFs focused on food, beverage, and consumer staples, but they pursue exposure through different indexes and screening methodologies.
  • FXG holds roughly 41 stocks with broader sector reach, including healthcare distributors such as CAH and MCK, while PBJ is a more concentrated, non-diversified fund of about 30 to 32 food-and-beverage names.
  • Both funds carry an expense ratio near 0.63%, placing them at the higher end relative to plain-vanilla consumer staples ETFs.
  • PBJ is a purer play on packaged foods, beverages, and food distribution, whereas FXG blends staples with healthcare and a multi-cap growth-and-value factor tilt.
  • On diversification, defensive breadth, and balanced factor construction, Tickeron's AI Verdict favors FXG of the two.

Why These Two ETFs Often Appear Together

Investors looking for defensive, consumer-oriented equity exposure frequently compare the First Trust Consumer Staples AlphaDEX Fund (FXG) and the Invesco Food & Beverage ETF (PBJ). Although both sit in the broader consumer staples universe, they are not interchangeable. FXG applies First Trust's AlphaDEX multi-factor screening across a wider staples segment, while PBJ focuses strictly on U.S. food and beverage companies selected through a quantitative momentum-and-quality model. I find it useful to examine their differences in sector exposure, concentration, and index methodology before deciding on relative positioning.

First Trust Consumer Staples AlphaDEX Fund (FXG) at a Glance

FXG seeks to track the StrataQuant Consumer Staples AlphaDEX Index, an enhanced index that selects stocks from the Russell 1000 universe using the AlphaDEX methodology. The approach ranks candidates on growth factors such as recent price appreciation and sales growth, alongside value factors including book value to price and cash flow to price. Selected names are divided into tiers and weighted in a modified equal-dollar fashion, with quarterly reconstitution and rebalancing. The fund holds approximately 41 positions. Representative top holdings include FRPT, CAH, PPC, POST, INGR, MKC, STZ, and MCK. Consumer staples account for the majority of assets, but the fund also carries a meaningful healthcare allocation through distributors like Cardinal Health and McKesson, plus smaller consumer cyclical and industrial stakes. FXG carries an expense ratio of approximately 0.63% and launched in May 2007. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Invesco Food & Beverage ETF (PBJ) at a Glance

PBJ seeks to track the Dynamic Food & Beverage Intellidex Index, a quantitative, rules-based benchmark composed of roughly 30 U.S. food and beverage companies. The Intellidex methodology evaluates constituents on factors including fundamental growth, valuation, investment timeliness, and risk, then applies a tiered weighting scheme. The index is rebalanced quarterly, and the fund is classified as non-diversified. The portfolio holds approximately 30 to 32 securities. Leading positions include KR, KDP, ADM, KO, SYY, CTVA, SBUX, and MNST. Subsector exposure spans packaged foods and meats, soft drinks and non-alcoholic beverages, food distributors, food retail, and agricultural products. PBJ carries a net expense ratio of approximately 0.63% and has operated since June 2005.

Industry and Thematic Context

Both ETFs operate within the consumer staples complex, a segment investors traditionally turn to for steadier earnings, pricing power, and dividend support during periods of macroeconomic uncertainty. Recent market cycles have been shaped by persistent food-price inflation, shifting grocery and restaurant demand, and the rise of weight-loss medications that have pressured volume expectations for some packaged-food and beverage producers. Consolidation activity and supply-chain normalization have also influenced earnings across processors, distributors, and retailers. Interest-rate expectations matter as well: staples typically act as a defensive equity sleeve, but their relative appeal can fade when risk appetite returns to growth-oriented sectors. Within this environment, the broader, healthcare-adjacent composition of FXG provides a somewhat different risk profile than PBJ's purer food-and-beverage tilt.

Performance and Positioning Comparison

Over recent weeks and months, PBJ has displayed firmer relative momentum, supported by strength across beverage and food-distribution names, while FXG has been more range-bound as its healthcare and protein-related holdings experienced uneven earnings cycles. PBJ's concentrated exposure can amplify both gains and drawdowns when food and beverage sentiment shifts, whereas FXG's wider roster and healthcare sleeve tend to smooth single-stock and single-subsector volatility. From a cost standpoint the two funds are essentially identical, so differences in fund performance stem primarily from index construction and sector mix rather than fees. FXG's growth-and-value AlphaDEX tilt and its inclusion of healthcare distributors provide defensive diversification, while PBJ offers cleaner thematic access to the food value chain.

Using Tickeron AI Tools for This Comparison

When comparing ETFs like these, I often turn to Tickeron’s AI Screener to quickly filter holdings by industry, factor exposure, and recent performance patterns. It helps surface how the broader healthcare tilt in one fund stacks up against the concentrated food-and-beverage focus in the other, giving a clearer view of diversification differences without manual spreadsheet work. This kind of targeted scan has become a regular part of my process for validating relative positioning across market cycles.

Tickeron AI Verdict

Weighing structural strength, cost efficiency, diversification profile, and risk exposure, Tickeron's AI would currently favor FXG between the two funds. Although PBJ has shown stronger near-term trend consistency and offers purer food-and-beverage exposure, FXG's broader roster of roughly 41 holdings, its added healthcare-distribution sleeve, and its balanced growth-and-value factor methodology provide a more diversified and defensively resilient profile at a nearly identical cost. This broader, less concentrated construction may offer more consistent relative positioning across shifting market cycles, making FXG the more robust probabilistic choice of the pair.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FXG, PBJ

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FXG sees MACD Histogram crosses below signal line

FXG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 38 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 73 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

Following a +1.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 176 of 272 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), PepsiCo (NASDAQ:PEP), Altria Group (NYSE:MO), McKesson Corp (NYSE:MCK), CVS HEALTH Corp (NYSE:CVS), Mondelez International (NASDAQ:MDLZ), Kroger Co (The) (NYSE:KR), Archer Daniels Midland Company (NYSE:ADM), Constellation Brands (NYSE:STZ).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Consumer Staples Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the consumer staples sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Market Cap

The average market capitalization across the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF is 51.47B. The market cap for tickers in the group ranges from 3.09B to 411.62B. KO holds the highest valuation in this group at 411.62B. The lowest valued company is FRPT at 3.09B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF was -3%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 2%. TSN experienced the highest price growth at 11%, while BG experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF was 22%. For the same stocks of the ETF, the average monthly volume growth was 57% and the average quarterly volume growth was 49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 48
Price Growth Rating: 47
SMR Rating: 59
Profit Risk Rating: 69
Seasonality Score: 10 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.